Enhancing Innate Anti-Viral Resistance Through A Community-Based Intervention - Generation Xchange

About

Brief Summary

This randomized controlled trial will test whether a recently developed community-based intergenerational mentoring program known as Generation Xchange (GenX) can enhance antiviral resistance in older African-American women and men in a low-SES urban community. Additional studies will identify the biological processes that promote resistance to respiratory virus infections and viral disease in older African-American women and men.

Primary Purpose
Basic science
Study Type
Interventional
Phase
N/A

Eligibility

Gender
All
Healthy Volunteers
Yes
Minimum Age
50 Years
Maximum Age
N/A

Inclusion Criteria:

Exclusion Criteria:

Join this Trial

Share:
Study Stats
Protocol No.
21-001388
Category
Infectious Diseases
Principal Investigator
Teresa Seeman
Contact
Steven Cole
Location
  • UCLA Westwood
For Providers
NCT No.
NCT05534425
For detailed technical eligibility, visit ClinicalTrials.gov.